SCHEMBL7691122

SCHEMBL7691122

CC(C)(C)c1cc(Nc2nc3cc4ccccc4cc3nc2Cl)n(-c2cccc(F)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 2/20 0.50
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.41
MAPK13 O15264 8/20 0.41
MAPK12 P53778 7/20 0.41
MAPK11 Q15759 7/20 0.41
MAPK9 P45984 2/20 0.40
DDR2 Q16832 2/20 0.40
JAK2 O60674 1/20 0.40
SRC P12931 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699510 0.84 MAPK14 (0.56) MAPK14LMNAMAPTHTTSMN1; SMN2
SCHEMBL7691226 0.83 MAPK14 (0.45) MAPK14LMNAMAPTHTTSMN1; SMN2
SCHEMBL7697861 0.83 MAPK14 (0.47) MAPK14MAPTMAPK13MAPK12MAPK11
SCHEMBL7700675 0.82 MAPK14 (0.43) MAPK14LMNAMAPTL3MBTL1MAPK13
SCHEMBL7693923 0.82 MAPK14 (0.45) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL7697564 0.82 MAPK14 (0.41) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL7696555 0.82 MAPK14 (0.46) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL7697591 0.81 MAPK14 (0.43) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL7690441 0.81 MAPK14 (0.47) MAPK14SMN1; SMN2MAPK13MAPK12MAPK11
SCHEMBL7691136 0.80 BRAF (0.46) MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed